The Role of Anti–Tumor Necrosis Factor Receptor Agents in Cancer Survivors: Does the Risk Justify the Benefit?

Autor: Chapman, Paul, Cranmer, Lee, Dixon, W.G., Hyrich, K.L., Patterson, John R., Symmons, D.P.M., Toporcer, Mary, Mastrangelo, Michael J.
Zdroj: In Seminars in Oncology 2010 37(1):11-19
Databáze: ScienceDirect